Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Bispecific Antibodies, Lymphoma

Judith Trotman

MBChB, FRACP

🏢Concord Repatriation General Hospital, University of Sydney🌐Australia

Director, Haematology Clinical Research Unit

55
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Judith Trotman leads haematology clinical research at Concord Hospital in Sydney and has been principal investigator of pivotal mosunetuzumab and glofitamab trials. She has advanced PET-based response assessment in lymphoma. Her work has helped bring bispecifics to the global standard of care.

Share:

🧪Research Fields 研究领域

mosunetuzumab
glofitamab
follicular lymphoma
PET-based response
Australian lymphoma trials

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Judith Trotman 的研究动态

Follow Judith Trotman's research updates

留下邮箱,当我们发布与 Judith Trotman(Concord Repatriation General Hospital, University of Sydney)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment